Evidence map›Paper›PMID 19096841›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2009

Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging.

Yusuke Inoue, Shigeru Kiryu, Kiyoko Izawa, Makoto Watanabe, Arinobu Tojo, Kuni Ohtomo

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Review
  2. Article
  3. Bioluminescent Imaging of Patient-Derived Brain Tumors in Live Mice.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Bioluminescent Systems for Theranostic Applications.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Continuous and Real-Time In Vivo Autobioluminescent Imaging in a Mouse Model.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yusuke InoueDepartment of Radiology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. inoueys-tky@umin.ac.jp
Shigeru Kiryu
Kiyoko Izawa
Makoto Watanabe
Arinobu Tojo
Kuni Ohtomo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe compared subcutaneous (SC) injection and intraperitoneal (IP) injection of D-luciferin for in vivo bioluminescence imaging (BLI) to determine the utility of SC injection.

methodsMice bearing SC tumours stably expressing firefly luciferase underwent in vivo BLI using SC and IP injection of D: -luciferin. BLI studies were repeated at an interval of 3 h using a given injection route to assess repeatability and using different injection routes to assess correlation. In mice bearing both SC and IP tumours, BLI was performed successively using intravenous (IV), SC, and IP injection of D: -luciferin. Haematological malignancy model mice underwent BLI using SC and IP injection.

resultsIn SC tumours, the peak time was slightly shorter and the peak signal was greater using SC injection than using IP injection. The repeatability of determining peak signals was comparable between the two injection routes, and a good correlation was observed between them. In mice bearing both SC and IP tumours, signals from IP tumours relative to those from SC tumours were much greater using IP injection than using IV or SC injection. In the haematological malignancy model, signals from the spleen relative to those from the bone marrow were greater using IP injection than using SC injection.

conclusionIn addition to rare injection failure, the IP injection of D: -luciferin led to the overestimation of signals from IP tissues. For BLI, SC injection was shown to be a convenient alternative to IP injection.

Indexed as

LuminescenceAnimalsBenzothiazolesCollagenDisease Models, AnimalDrug CombinationsFemaleHumansInjections, IntraperitonealInjections, SubcutaneousLamininLuciferases, FireflyLuminescent MeasurementsMiceMice, NudeNeoplasm TransplantationBenzothiazolesCollagenD-luciferinDrug CombinationsLamininLuciferases, FireflymatrigelProteoglycans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.